Pre-operative treatment of uterine fibroids approved by European Commission, Shinpoong says

Published: 2012-03-08 06:56:00

Updated: 2012-03-08 06:56:00

Shinpoong Pharmaceutical Co. says the European Commission (EC) has recently granted marketing authorization to Esmya (ulipristal acetate) 5mg tablets as pre-operative treatment of moderate to severe symptoms of uterine fibroids.

Shinpooong signed an exclusive licensing agreement with France ba...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK